Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

This study has been completed.

Sponsor:

Information provided by:

OncoGenex Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00034164

First received: April 23, 2002

Last updated: June 2, 2009

Last verified: June 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2007
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)